• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Leukemia

FDA Logo
June 2, 2013
News Center/Pharmaceutical News

FDA approves Gleevec for children with acute lymphoblastic leukemia

[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). ALL is the most common type of pediatric cancer, affecting approximately 2,900 children annually,

More
FDA Logo
News Center/Pharmaceutical News

FDA approves Gleevec for children with acute lymphoblastic leukemia

June 2, 2013

[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with

More
  • Repurposing the anthelmintic drug Niclosamide
  • Patient-Centric Marketing in the Life Science Industry: Putting the Focus on Patient Needs
  • Pharmaceutical Equipment Manufacturer Unveils Custom Wash Rack Services 
  • Merging mind and machine: Augmented intelligence and the limits of AI in medical communications
  • Breaking Free from Addiction: Exploring Online Suboxone Clinics in San Antonio, TX

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop